These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24226484)

  • 21. Lipopolysaccaride-binding peptides obtained by phage display method.
    Matsumoto M; Horiuchi Y; Yamamoto A; Ochiai M; Niwa M; Takagi T; Omi H; Kobayashi T; Suzuki MM
    J Microbiol Methods; 2010 Jul; 82(1):54-8. PubMed ID: 20412822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The tug of war between Al
    Messias A; Santos DES; Pontes FJS; Soares TA
    Phys Chem Chem Phys; 2021 Jul; 23(28):15127-15137. PubMed ID: 34254086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cations on the structure of bilayers formed by lipopolysaccharides isolated from Pseudomonas aeruginosa PAO1.
    Kucerka N; Papp-Szabo E; Nieh MP; Harroun TA; Schooling SR; Pencer J; Nicholson EA; Beveridge TJ; Katsaras J
    J Phys Chem B; 2008 Jul; 112(27):8057-62. PubMed ID: 18549267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Redefining the requisite lipopolysaccharide structure in Escherichia coli.
    Meredith TC; Aggarwal P; Mamat U; Lindner B; Woodard RW
    ACS Chem Biol; 2006 Feb; 1(1):33-42. PubMed ID: 17163638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipopolysaccharide bilayer structure: effect of chemotype, core mutations, divalent cations, and temperature.
    Snyder S; Kim D; McIntosh TJ
    Biochemistry; 1999 Aug; 38(33):10758-67. PubMed ID: 10451371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Modification of lipopolysaccharides as one of the ways of adaptation of pathogenic bacteria and their populations to biotic and abiotic environmental factors].
    Shylina IuV; Molozhava OS
    Tsitol Genet; 2004; 38(2):65-80. PubMed ID: 15131973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Divalent cation induced re-entrant condensation behavior for lipopolysaccharides.
    Frimpong AO; Xu X; Jia X; Zhang Y
    J Chem Phys; 2022 Oct; 157(15):154902. PubMed ID: 36272789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipopolysaccharide chemotyping.
    Chart H
    Methods Mol Biol; 1995; 46():41-8. PubMed ID: 7550717
    [No Abstract]   [Full Text] [Related]  

  • 29. Phase behavior, supramolecular structure, and molecular conformation of lipopolysaccharide.
    Seydel U; Labischinski H; Kastowsky M; Brandenburg K
    Immunobiology; 1993 Apr; 187(3-5):191-211. PubMed ID: 8330897
    [No Abstract]   [Full Text] [Related]  

  • 30. Spontaneous insertion of lipopolysaccharide into lipid membranes from aqueous solution.
    Alam JM; Yamazaki M
    Chem Phys Lipids; 2011 Feb; 164(2):166-74. PubMed ID: 21195067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chapter 2: Kill the bacteria...and also their messengers?
    Munford R; Lu M; Varley A
    Adv Immunol; 2009; 103():29-48. PubMed ID: 19755182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial lipopolysaccharides form physically cross-linked, two-dimensional gels in the presence of divalent cations.
    Herrmann M; Schneck E; Gutsmann T; Brandenburg K; Tanaka M
    Soft Matter; 2015 Aug; 11(30):6037-44. PubMed ID: 26136185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The chemical structure of bacterial endotoxin in relation to bioactivity.
    Rietschel ET; Kirikae T; Schade FU; Ulmer AJ; Holst O; Brade H; Schmidt G; Mamat U; Grimmecke HD; Kusumoto S
    Immunobiology; 1993 Apr; 187(3-5):169-90. PubMed ID: 8330896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biosynthesis, transport, and modification of lipid A.
    Trent MS
    Biochem Cell Biol; 2004 Feb; 82(1):71-86. PubMed ID: 15052329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The lipooligosaccharides of pathogenic gram-negative bacteria.
    Preston A; Mandrell RE; Gibson BW; Apicella MA
    Crit Rev Microbiol; 1996; 22(3):139-80. PubMed ID: 8894399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular modeling analysis of the interaction of novel bis-cationic ligands with the lipid A moiety of lipopolysaccharide.
    Guo JX; Wood SJ; David SA; Lushington GH
    Bioorg Med Chem Lett; 2006 Feb; 16(3):714-7. PubMed ID: 16266804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The bacterial outer membrane as a drug barrier.
    Hancock RE
    Trends Microbiol; 1997 Jan; 5(1):37-42. PubMed ID: 9025234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of action of bactericidal/permeability-increasing protein BPI on reconstituted outer membranes of gram-negative bacteria.
    Wiese A; Brandenburg K; Carroll SF; Rietschel ET; Seydel U
    Biochemistry; 1997 Aug; 36(33):10311-9. PubMed ID: 9254630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipopolysaccharides in bacterial membranes act like cholesterol in eukaryotic plasma membranes in providing protection against melittin-induced bilayer lysis.
    Allende D; McIntosh TJ
    Biochemistry; 2003 Feb; 42(4):1101-8. PubMed ID: 12549932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions between Mutant Bacterial Lipopolysaccharide (LPS-Ra) Surface Layers: Surface Vesicles, Membrane Fusion, and Effect of Ca
    Redeker C; Briscoe WH
    Langmuir; 2019 Dec; 35(48):15739-15750. PubMed ID: 31604373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.